EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Management of Co-Morbidities in Patients with Heart Failure - Iron Deficiency

Stephan Von Haehling, Ewa Jankowska, Stefan D Anker

International Cardiovascular Forum Journal · 2017

DOI: 10.17987/icfj.v10i0.440 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Cardiovascular Forum Journal, 2017. Verfasst von Stephan Von Haehling und 2 weiteren Autor:innen. Die Arbeit wurde bisher 5-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Co-morbidities have been recognised as playing a crucial role in the progress of the older patient with HF in particular. The 2016 ESC/HFA HF guidelines stress the significance of co-morbidities more than any previous guidelines have. Iron deficiency is a co-morbidity, that has received very little attention until the last decade, as evidence has accumulated both for the significance of this co-morbidity and the emergence of safe effective therapies that appear to offer significant benefits to the HF population who suffer this co-morbidity.

Zitieren

APA

Haehling, S. V., Jankowska, E., & Anker, S. D. (2017). The Management of Co-Morbidities in Patients with Heart Failure - Iron Deficiency. International Cardiovascular Forum Journal. https://doi.org/10.17987/icfj.v10i0.440

Vancouver

Haehling SV, Jankowska E, Anker SD. The Management of Co-Morbidities in Patients with Heart Failure - Iron Deficiency. International Cardiovascular Forum Journal. 2017. doi:10.17987/icfj.v10i0.440

BibTeX
@article{Haehling2017,
  author = {Haehling, Stephan Von and Jankowska, Ewa and Anker, Stefan D},
  title = {The Management of Co-Morbidities in Patients with Heart Failure - Iron Deficiency},
  journal = {International Cardiovascular Forum Journal},
  year = {2017},
  doi = {10.17987/icfj.v10i0.440}
}
Kostenlos starten →